Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Comment by Sarb99on Aug 18, 2020 4:40pm
213 Views
Post# 31424996

RE:RE:RE:QSC Covid-19 test price go up again today

RE:RE:RE:QSC Covid-19 test price go up again todayYou or I do not control the share price, open market does. Some believe QSC can be $2-$5 in near future and are holding for long term. Many other wants to make few cents today. So, on July 29th QSC was trading at .10 cents and anyone brought between .10 to .20 wants to take out profit and move to next play. So, they are selling at these prices, unless selling dry down at these prices, big boys going to keep the share price at these levels.
 
If you can buy at .20 why would you .25, Once these penny flippers are taken out at these prices, then QSC should move up. We can see Lyher testing is real, approved by FDA, QSC sales centres are real, demand is real, but they opened only 2 locations for now. As QSC open more locations next few weeks, we should move up. Plus, I think company needs to update us on other orders they announced in May.

We need update on Biocorp Clinical Lab contract from QSC

Biocorp Clinical Lab started hiring Mobile Phlebotomist last week. I am wondering are they buying those 500k covid-19 test kits from us or someone else. We need clarification from the management. Timing is the same as Las Vegas Testing sites launch.


Job description involves facilitating larger company specimen collections, possibly with a partner, at a single location. One location or possibly 2 locations may be required per day. Company sites will be located in Hollywood/Los Angeles area. Travel time for specimen drop off and supply pick up may be needed in Whittier. Minor handling of paperwork, including paying special attention to details when process and handling specimens. Specimen collection includes nasal swabs. Technician for this position will need to be a person who can adapt to change quickly, highly professional, organized, and provide friendly customer service.

https://www.ragns.us/mobile-phlebotomist-job-in-hollywood-ca-view-c639dfb1e5b32e5b

<< Previous
Bullboard Posts
Next >>